The mini-review in Rheumatology (2025) examines the link between interstitial lung disease (ILD), antineutrophil cystoplasmic antibodies (ANCA), and microscopic polyangiitis (MPA). It delves into the radiographic and histopathologic evidence, as well as genetic factors that may contribute to the development of these conditions. The review suggests a possible pathogenesis for how ILD and MPO-ANCA are related to MPA.
Furthermore, the article outlines a practical approach for clinicians treating patients who either present with ILD and test positive for ANCA or have MPA with ILD. The recommended treatment strategies are informed by the latest guidelines for managing both ILD and ANCA-associated vasculitis. This approach aims to provide a clear direction for healthcare providers in the diagnosis and management of these complex conditions.
Clinical Trials
This is a list of upcoming or ongoing clinical trials that are actively recruiting and have been listed or updated in the last two weeks: